STOCK TITAN

[Form 4] Columbia Financial, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Kemly Thomas J., who serves as President & CEO and a director of Columbia Financial, Inc. (CLBK), reported insider transactions dated 08/08/2025. The filing shows a disposition of 233,808 common shares and the purchase of 124.7125 phantom stock units under the company’s rabbi trust at a price of $14.33 per unit; those phantom units are to be settled in shares upon distribution. Following the reported transactions, the filing lists 65,320.1776 shares beneficially owned, many held indirectly through plans including a 401(k), ESOP, SERP, spouse, and multiple stock award vehicles.

The report also discloses outstanding stock option positions granted under the 2019 Equity Incentive Plan: 656,471 options at $15.60 (fully vested, exp. 07/23/2029), 37,894 at $15.94 (exp. 05/01/2033), 37,168 at $16.49 (exp. 03/06/2034), and 94,749 at $16.23 (exp. 03/03/2035). Several stock awards include time- and performance-based vesting conditions described in the filing.

Kemly Thomas J., che ricopre la carica di Presidente & CEO e direttore di Columbia Financial, Inc. (CLBK), ha segnalato operazioni insider in data 08/08/2025. La comunicazione indica una cessione di 233,808 azioni ordinarie e l'acquisto di 124.7125 unità azionarie fantasma nel rabbi trust della società al prezzo di $14.33 per unità; tali unità fantasma saranno convertite in azioni al momento della distribuzione. A seguito delle operazioni riportate, la comunicazione elenca la titolarità beneficiaria di 65,320.1776 azioni, molte delle quali detenute indirettamente tramite piani quali 401(k), ESOP, SERP, il coniuge e diversi strumenti di assegnazione azionaria.

Il rapporto riporta inoltre posizioni di opzioni su azioni ancora in essere concesse ai sensi del 2019 Equity Incentive Plan: 656,471 opzioni a $15.60 (completamente maturate, scad. 07/23/2029), 37,894 a $15.94 (scad. 05/01/2033), 37,168 a $16.49 (scad. 03/06/2034) e 94,749 a $16.23 (scad. 03/03/2035). Diversi premi azionari includono condizioni di maturazione basate su tempo e performance descritte nella comunicazione.

Kemly Thomas J., quien se desempeña como Presidente & CEO y director de Columbia Financial, Inc. (CLBK), informó transacciones de insider con fecha 08/08/2025. La presentación muestra una disposición de 233,808 acciones ordinarias y la compra de 124.7125 unidades de acciones fantasma bajo el rabbi trust de la compañía a un precio de $14.33 por unidad; dichas unidades fantasma se liquidarán en acciones al momento de la distribución. Tras las transacciones informadas, la presentación enumera 65,320.1776 acciones en propiedad beneficiaria, muchas mantenidas indirectamente a través de planes como 401(k), ESOP, SERP, la cónyuge y varios mecanismos de adjudicación de acciones.

El informe también revela posiciones de opciones sobre acciones pendientes otorgadas en virtud del 2019 Equity Incentive Plan: 656,471 opciones a $15.60 (totalmente ejercitadas, venc. 07/23/2029), 37,894 a $15.94 (venc. 05/01/2033), 37,168 a $16.49 (venc. 03/06/2034) y 94,749 a $16.23 (venc. 03/03/2035). Varios premios en acciones incluyen condiciones de consolidación por tiempo y rendimiento descritas en la presentación.

Kemly Thomas J.는 Columbia Financial, Inc. (CLBK)의 사장 겸 CEO이자 이사로서 08/08/2025자 내부자 거래를 보고했습니다. 신고서에는 233,808주 보통주 처분과 회사의 라비 트러스트에서 124.7125개의 팬텀 스톡 유닛 매입이 있으며 단위당 가격은 $14.33로 기재되어 있습니다. 이 팬텀 유닛들은 배분 시 주식으로 정산될 예정입니다. 보고된 거래 이후 신고서에는 65,320.1776주의 실질적 보유가 기재되어 있으며, 이들 중 다수는 401(k), ESOP, SERP, 배우자 및 여러 주식 보상 수단을 통해 간접적으로 보유되고 있습니다.

보고서는 또한 2019 Equity Incentive Plan에 따라 부여된 미결 옵션 포지션을 공개합니다: $15.60 행사가 656,471옵션(완전 베스팅, 만료 07/23/2029), $15.94 행사가 37,894옵션(만료 05/01/2033), $16.49 행사가 37,168옵션(만료 03/06/2034)$16.23 행사가 94,749옵션(만료 03/03/2035). 여러 주식 수여는 신고서에 설명된 시간 기반 및 성과 기반 베스팅 조건을 포함합니다.

Kemly Thomas J., qui exerce les fonctions de President & CEO et administrateur de Columbia Financial, Inc. (CLBK), a déclaré des transactions d'initié datées du 08/08/2025. Le dépôt indique une cession de 233,808 actions ordinaires et l'achat de 124.7125 unités d'actions fantômes au sein du rabbi trust de la société au prix de 14,33 $ par unité ; ces unités fantômes seront réglées en actions lors de la distribution. À la suite des transactions déclarées, le dépôt recense 65,320.1776 actions détenues à titre bénéficiaire, dont beaucoup sont détenues indirectement via des plans tels que le 401(k), l'ESOP, le SERP, le conjoint et plusieurs mécanismes d'attribution d'actions.

Le rapport révèle également des positions d'options sur actions en cours, accordées dans le cadre du 2019 Equity Incentive Plan : 656,471 options à 15,60 $ (totalement acquises, échéance 07/23/2029), 37,894 à 15,94 $ (échéance 05/01/2033), 37,168 à 16,49 $ (échéance 03/06/2034) et 94,749 à 16,23 $ (échéance 03/03/2035). Plusieurs attributions d'actions comportent des conditions d'acquisition fondées sur le temps et la performance, décrites dans le dépôt.

Kemly Thomas J., der als President & CEO und Direktor von Columbia Financial, Inc. (CLBK) tätig ist, meldete Insider-Transaktionen mit Datum 08/08/2025. Die Einreichung weist eine Veräußerung von 233,808 Stammaktien sowie den Kauf von 124.7125 Phantom-Aktieneinheiten im Rahmen des rabbi trust des Unternehmens zu einem Preis von $14.33 pro Einheit aus; diese Phantom-Einheiten sollen bei Ausschüttung in Aktien abgewickelt werden. Nach den gemeldeten Transaktionen listet die Einreichung 65,320.1776 Aktien als wirtschaftlich gehalten auf, viele davon indirekt über Pläne wie 401(k), ESOP, SERP, die Ehefrau und verschiedene Aktienzuteilungsvehikel gehalten.

Der Bericht offenbart ferner ausstehende Aktienoptionspositionen, die gemäß dem 2019 Equity Incentive Plan gewährt wurden: 656,471 Optionen zu $15.60 (vollständig unverfallbar, Abl. 07/23/2029), 37,894 zu $15.94 (Abl. 05/01/2033), 37,168 zu $16.49 (Abl. 03/06/2034) und 94,749 zu $16.23 (Abl. 03/03/2035). Mehrere Aktienzuteilungen enthalten in der Einreichung beschriebene zeit- und leistungsabhängige Vesting-Bedingungen.

Positive
  • Continued material ownership: Reports 65,320.1776 shares beneficially owned following transactions.
  • Equity-linked compensation: Holds multiple stock option tranches including 656,471 options at $15.60 (fully vested).
  • Long-term alignment: Acquired 124.7125 phantom stock units under the Stock Based Deferral Plan, which will be settled in shares upon distribution.
Negative
  • Large insider sale: Disposed of 233,808 common shares as reported in the filing.
  • Significant portion of awards are performance-vested: Several stock awards vest only upon achievement of specified performance criteria, delaying realization of those shares.

Insights

TL;DR: Significant insider sale of 233,808 shares, but CEO retains material equity and multiple long-dated option tranches.

The reported sale of 233,808 shares is a sizeable, explicit disposition and is noteworthy because insider sales can signal liquidity needs or portfolio rebalancing. Offsetting that, the filing shows continued material ownership—65,320.1776 shares beneficially owned including indirect plan holdings—and multiple option grants with staggered expirations, including a large fully vested tranche of 656,471 options. The combination of immediate sale and preserved long-term incentives (phantom units and performance-vested awards) suggests a mix of near-term liquidity action and ongoing alignment with shareholder value through incentive structures. Analysis should focus on the magnitude of the sale relative to her total holdings and any scheduled option exercises.

TL;DR: Insider retains substantial equity and programmatic awards, but the large disclosed sale warrants disclosure scrutiny.

The filing documents a programmatic acquisition via the rabbi trust and multiple equity award schedules with performance vesting, which align executive and shareholder interests when vesting conditions are met. However, the explicit disposition of 233,808 shares is material from a governance and disclosure perspective and should be monitored alongside future filings for patterns. The presence of indirect holdings through retirement and deferred compensation plans, plus multi-year option schedules, indicates compensation is heavily equity-linked and subject to plan terms described in the filing.

Kemly Thomas J., che ricopre la carica di Presidente & CEO e direttore di Columbia Financial, Inc. (CLBK), ha segnalato operazioni insider in data 08/08/2025. La comunicazione indica una cessione di 233,808 azioni ordinarie e l'acquisto di 124.7125 unità azionarie fantasma nel rabbi trust della società al prezzo di $14.33 per unità; tali unità fantasma saranno convertite in azioni al momento della distribuzione. A seguito delle operazioni riportate, la comunicazione elenca la titolarità beneficiaria di 65,320.1776 azioni, molte delle quali detenute indirettamente tramite piani quali 401(k), ESOP, SERP, il coniuge e diversi strumenti di assegnazione azionaria.

Il rapporto riporta inoltre posizioni di opzioni su azioni ancora in essere concesse ai sensi del 2019 Equity Incentive Plan: 656,471 opzioni a $15.60 (completamente maturate, scad. 07/23/2029), 37,894 a $15.94 (scad. 05/01/2033), 37,168 a $16.49 (scad. 03/06/2034) e 94,749 a $16.23 (scad. 03/03/2035). Diversi premi azionari includono condizioni di maturazione basate su tempo e performance descritte nella comunicazione.

Kemly Thomas J., quien se desempeña como Presidente & CEO y director de Columbia Financial, Inc. (CLBK), informó transacciones de insider con fecha 08/08/2025. La presentación muestra una disposición de 233,808 acciones ordinarias y la compra de 124.7125 unidades de acciones fantasma bajo el rabbi trust de la compañía a un precio de $14.33 por unidad; dichas unidades fantasma se liquidarán en acciones al momento de la distribución. Tras las transacciones informadas, la presentación enumera 65,320.1776 acciones en propiedad beneficiaria, muchas mantenidas indirectamente a través de planes como 401(k), ESOP, SERP, la cónyuge y varios mecanismos de adjudicación de acciones.

El informe también revela posiciones de opciones sobre acciones pendientes otorgadas en virtud del 2019 Equity Incentive Plan: 656,471 opciones a $15.60 (totalmente ejercitadas, venc. 07/23/2029), 37,894 a $15.94 (venc. 05/01/2033), 37,168 a $16.49 (venc. 03/06/2034) y 94,749 a $16.23 (venc. 03/03/2035). Varios premios en acciones incluyen condiciones de consolidación por tiempo y rendimiento descritas en la presentación.

Kemly Thomas J.는 Columbia Financial, Inc. (CLBK)의 사장 겸 CEO이자 이사로서 08/08/2025자 내부자 거래를 보고했습니다. 신고서에는 233,808주 보통주 처분과 회사의 라비 트러스트에서 124.7125개의 팬텀 스톡 유닛 매입이 있으며 단위당 가격은 $14.33로 기재되어 있습니다. 이 팬텀 유닛들은 배분 시 주식으로 정산될 예정입니다. 보고된 거래 이후 신고서에는 65,320.1776주의 실질적 보유가 기재되어 있으며, 이들 중 다수는 401(k), ESOP, SERP, 배우자 및 여러 주식 보상 수단을 통해 간접적으로 보유되고 있습니다.

보고서는 또한 2019 Equity Incentive Plan에 따라 부여된 미결 옵션 포지션을 공개합니다: $15.60 행사가 656,471옵션(완전 베스팅, 만료 07/23/2029), $15.94 행사가 37,894옵션(만료 05/01/2033), $16.49 행사가 37,168옵션(만료 03/06/2034)$16.23 행사가 94,749옵션(만료 03/03/2035). 여러 주식 수여는 신고서에 설명된 시간 기반 및 성과 기반 베스팅 조건을 포함합니다.

Kemly Thomas J., qui exerce les fonctions de President & CEO et administrateur de Columbia Financial, Inc. (CLBK), a déclaré des transactions d'initié datées du 08/08/2025. Le dépôt indique une cession de 233,808 actions ordinaires et l'achat de 124.7125 unités d'actions fantômes au sein du rabbi trust de la société au prix de 14,33 $ par unité ; ces unités fantômes seront réglées en actions lors de la distribution. À la suite des transactions déclarées, le dépôt recense 65,320.1776 actions détenues à titre bénéficiaire, dont beaucoup sont détenues indirectement via des plans tels que le 401(k), l'ESOP, le SERP, le conjoint et plusieurs mécanismes d'attribution d'actions.

Le rapport révèle également des positions d'options sur actions en cours, accordées dans le cadre du 2019 Equity Incentive Plan : 656,471 options à 15,60 $ (totalement acquises, échéance 07/23/2029), 37,894 à 15,94 $ (échéance 05/01/2033), 37,168 à 16,49 $ (échéance 03/06/2034) et 94,749 à 16,23 $ (échéance 03/03/2035). Plusieurs attributions d'actions comportent des conditions d'acquisition fondées sur le temps et la performance, décrites dans le dépôt.

Kemly Thomas J., der als President & CEO und Direktor von Columbia Financial, Inc. (CLBK) tätig ist, meldete Insider-Transaktionen mit Datum 08/08/2025. Die Einreichung weist eine Veräußerung von 233,808 Stammaktien sowie den Kauf von 124.7125 Phantom-Aktieneinheiten im Rahmen des rabbi trust des Unternehmens zu einem Preis von $14.33 pro Einheit aus; diese Phantom-Einheiten sollen bei Ausschüttung in Aktien abgewickelt werden. Nach den gemeldeten Transaktionen listet die Einreichung 65,320.1776 Aktien als wirtschaftlich gehalten auf, viele davon indirekt über Pläne wie 401(k), ESOP, SERP, die Ehefrau und verschiedene Aktienzuteilungsvehikel gehalten.

Der Bericht offenbart ferner ausstehende Aktienoptionspositionen, die gemäß dem 2019 Equity Incentive Plan gewährt wurden: 656,471 Optionen zu $15.60 (vollständig unverfallbar, Abl. 07/23/2029), 37,894 zu $15.94 (Abl. 05/01/2033), 37,168 zu $16.49 (Abl. 03/06/2034) und 94,749 zu $16.23 (Abl. 03/03/2035). Mehrere Aktienzuteilungen enthalten in der Einreichung beschriebene zeit- und leistungsabhängige Vesting-Bedingungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kemly Thomas J.

(Last) (First) (Middle)
19-01 ROUTE 208 NORTH

(Street)
FAIR LAWN NJ 07410

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Columbia Financial, Inc. [ CLBK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 A 124.7125(1) A $14.33 65,320.1776 I By Stock-Based Deferral Plan
Common Stock 233,808 D
Common Stock 40,946 I By 401(k)
Common Stock 7,620 I By ESOP
Common Stock 32,597 I By SERP
Common Stock 41,572 I By SIM
Common Stock 5,933 I By Spouse
Common Stock 43,411 I By Stock Award II(2)
Common Stock 50,686 I By Stock Award III(3)
Common Stock 54,690 I By Stock Award IV(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) $15.6 07/23/2020(5) 07/23/2029 Common Stock 656,471 656,471 D
Stock Options (right to buy) $15.94 05/01/2024(6) 05/01/2033 Common Stock 37,894 37,894 D
Stock Options (right to buy) $16.49 03/06/2025(7) 03/06/2034 Common Stock 37,168 37,168 D
Stock Options (right to buy) $16.23 03/03/2026(8) 03/03/2035 Common Stock 94,749 94,749 D
Explanation of Responses:
1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on May 1, 2024; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
3. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
4. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
5. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
6. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on May 1, 2024.
7. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
8. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
Remarks:
/s/ Dennis E. Gibney, Power of Attorney 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Columbia Financial CEO Kemly Thomas report on Form 4 (CLBK)?

The form reports a disposition of 233,808 common shares and the purchase of 124.7125 phantom stock units under the rabbi trust at $14.33 per unit.

How many shares does Kemly Thomas beneficially own after the reported transactions (CLBK)?

The filing lists 65,320.1776 shares beneficially owned following the reported transactions, many held indirectly through company plans and by spouse.

What stock options and strike prices does the Form 4 disclose for Kemly Thomas (CLBK)?

Disclosed options: 656,471 at $15.60 (fully vested, exp. 07/23/2029), 37,894 at $15.94 (exp. 05/01/2033), 37,168 at $16.49 (exp. 03/06/2034), and 94,749 at $16.23 (exp. 03/03/2035).

Were any of the reported equity awards subject to performance-based vesting (CLBK)?

Yes. The filing states several Stock Awards (Stock Award II, III, IV) include performance-based vesting criteria and time-based vesting schedules as described in the explanations.

Who filed or signed the Form 4 for Kemly Thomas (CLBK)?

The Form 4 shows the filing was executed under power of attorney by Dennis E. Gibney as indicated in the signature block.
Columbia Financ

NASDAQ:CLBK

CLBK Rankings

CLBK Latest News

CLBK Latest SEC Filings

CLBK Stock Data

1.59B
26.84M
74.42%
13.23%
1.63%
Banks - Regional
Savings Institution, Federally Chartered
Link
United States
FAIR LAWN